Development Stability Testing for Inhaled and Nasal Drug Products
Controlled conditions. Trusted data.
Proveris Labs delivers GMP-compliant development stability studies for all major orally inhaled and nasal devices, producing reliable, submission-ready data. We provide end-to-end program management or targeted testing support, ensuring consistent, reproducible results you can trust.
Comprehensive Stability Support
We support your ICH stability requirements with flexible services, including:
Full stability testing across multiple pull points
Pilot stability studies to optimize study design
Custom protocols tailored to unique regulatory or product needs
Controlled Storage Conditions
Proveris offers a broad range of temperature- and humidity-controlled storage conditions—available at our facilities or through qualified third parties we manage —to replicate real-world environments for inhaled and nasal drug products. Standard options include:
- 25°C ± 2°C / 60%RH ± 5%RH
- 25°C ± 2°C / 40%RH ± 5%RH
- 30°C ± 2°C / 65%RH ± 5%RH
- 40°C ± 2°C / 75%RH ± 5%RH
- 40°C ± 2°C / 25%RH ± 5%RH
- 60°C ± 2°C
- 5°C ± 3°C
- -20°C ± 5°C
- -70°C ± 15°C
- Custom conditions and validations available
Our approach ensures every study is conducted under well-controlled, reproducible conditions to generate reliable, regulatory-ready data.
Why Proveris Stability Services
GMP-compliant processes for regulatory confidence
Flexible program management
Full-service or targeted testing support
Comprehensive ICH guidance for OINDPs
Ready to Accelerate Your Goals?
Schedule a 30-minute consultation and see how Proveris Labs can accelerate your goals. Contact us today.